サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463687

アジア太平洋の新生児スクリーニング：2030年市場予測- 地域別分析- 製品タイプ、技術、検査タイプ、エンドユーザー別

Asia Pacific Newborn Screening Market Forecast to 2030 - Regional Analysis - by Product Type (Reagents and Assay Kits, and Instruments), Technology, Test Type, and End User (Hospitals and Clinics, and Diagnostic Laboratories)
出版日: | 発行: The Insight Partners | ページ情報: 英文 107 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
アジア太平洋の新生児スクリーニング：2030年市場予測- 地域別分析- 製品タイプ、技術、検査タイプ、エンドユーザー別
出版日: 2024年02月07日
発行: The Insight Partners
ページ情報: 英文 107 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の新生児スクリーニング市場は、2022年に2億7,013万米ドルと評価され、2030年には6億214万米ドルに達すると予測され、2022年から2030年までのCAGRは10.5%で成長すると予測されています。

新生児の遺伝子スクリーニングがアジア太平洋の新生児スクリーニング市場を活性化。

病状の遺伝的原因に関する知識の深まりやヘルスケア技術の進歩に伴い、新生児の包括的な遺伝子スクリーニングの需要が高まっています。その結果、新生児スクリーニング市場の企業は、革新的で費用対効果の高いスクリーニング・ソリューションを開発しています。YescartaとZyntegloは、大細胞型B細胞リンパ腫とβ-サラセミアに対する認可された遺伝子治療の2つの例です。さらに、出生時に疾患に対する遺伝的素因を特定する能力を付与する技術の出現は、個別化ヘルスケアへの道を開き、精密医療という広範な傾向と一致します。

妊娠中の遺伝性疾患のスクリーニングは、妊娠に関連する問題の早期発見にも重点を置いています。次世代シーケンサーは、すべての染色体における異数体（ダウン症候群やトリソミー21など）や部分的な染色体異常（重複や欠失）の検出において95％以上の感度で新生児の出生前スクリーニングを支援します。蛍光in-situハイブリダイゼーション（FISH）は、鎌状赤血球貧血のような単発性疾患を検出するために使用されます。母体血漿を用いた無細胞胎児DNAアプローチのような非侵襲的手順は、遺伝子検査における最近の進歩です。胚DNAはその大きさの違いから母体DNA片と区別することができます。蛍光プローブを用いたリアルタイムPCR、ショットガンシーケンス（SolexaまたはIllumina）、あるいは巨大なターゲットパラレルシーケンスを用いて、胎児の病状に関連するDNAを調べることができます。これにより、この種の遺伝子スクリーニングがさらに研究されれば、医師は特定の薬理療法（薬理遺伝学）による早期の分子介入を行ったり、細胞、組織、臓器を物理的、化学的に変化させたりすることができるようになります。このように、乳児の遺伝性疾患スクリーニング方法の進歩は、新生児スクリーニング市場全体にとって計り知れない可能性を秘めています。

アジア太平洋の新生児スクリーニング市場概要

アジア太平洋の新生児スクリーニング市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋に区分されます。アジア太平洋の新生児スクリーニング市場は、日本、中国、インド、韓国、オーストラリア、その他アジア太平洋に区分されます。アジア太平洋は、2022年から2030年にかけて世界の新生児スクリーニング市場で最も急成長する地域となる見込みです。この地域における市場の成長予測は、新生児の出生数の多さ、先天性疾患の有病率の急上昇、新生児の先天性異常の早期診断に関する意識の高まり、新生児スクリーニングのためのより良いソリューションの提供に向けて活動している組織の存在と関連づけることができます。

アジア太平洋における新生児スクリーニングは牽引力を増しており、中国、インド、その他の国々の政府機関は、出生率の高さから新生児スクリーニング・プログラムを実施する必要があります。国連国際児童緊急基金（UNICEF）によると、インドでは1日に67,385人の赤ちゃんが誕生しており、1日に世界で記録される出産の6分の1を占めています。さらに、Worldmapperによると、2022年には2300万人、次いで中国の1,000万人の赤ちゃんが誕生しています。出生率の絶え間ない高騰に伴い、アジア太平洋の他の国と同様に、インドでも乳幼児ケアへの注目が高まっています。

アジア太平洋の新生児スクリーニング市場の収益と2030年までの予測（金額）

アジア太平洋の新生児スクリーニング市場のセグメンテーション

アジア太平洋の新生児スクリーニング市場は、製品タイプ、技術、検査タイプ、エンドユーザー、国によって区分されます。

製品タイプ別に見ると、アジア太平洋の新生児スクリーニング市場は試薬・アッセイキットと機器に二分されます。2022年のアジア太平洋の新生児スクリーニング市場シェアは、試薬・アッセイキットセグメントが大きくなっています。試薬・アッセイキット分野はDNAベースアッセイ、免疫アッセイ、酵素アッセイに細分化されます。機器セグメントは、新生児障害スクリーニング機器、パルスオキシメーター、新生児聴覚スクリーニング機器、その他の機器に細分化されます。

技術面では、アジア太平洋の新生児スクリーニング市場はタンデム質量分析（TMS）、分子アッセイ、免疫アッセイと酵素アッセイ、パルスオキシメトリースクリーニング技術、その他の技術に分類されます。パルスオキシメトリースクリーニング技術セグメントは、2022年にアジア太平洋の新生児スクリーニング市場で最大のシェアを占めました。

検査タイプに基づき、アジア太平洋の新生児スクリーニング市場は、乾燥血液スポット検査、聴覚スクリーン検査、重症先天性心疾患（CCHD）検査、その他の検査タイプに分類されます。2022年には、乾燥血液スポット検査分野がアジア太平洋の新生児スクリーニング市場で最大のシェアを占めました。

エンドユーザー別では、アジア太平洋の新生児スクリーニング市場は病院・診療所と診断研究所に区分されます。病院・診療所セグメントは、2022年にアジア太平洋の新生児スクリーニング市場でより大きなシェアを占めました。

国別では、アジア太平洋の新生児スクリーニング市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋に分類されます。中国は2022年にアジア太平洋の新生児スクリーニング市場を独占しました。

Bio-Rad Laboratories Inc、LifeCell International Pvt Ltd、Masimo Corp、Medtronic Plc、Natus Medical Inc、PerkinElmer Inc、Trivitron Healthcare Pvt Ltd、Waters Corpは、アジア太平洋の新生児スクリーニング市場で事業を展開している大手企業の一部です。

目次

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の新生児スクリーニング市場：主要産業力学

  • 市場促進要因
    • 新生児スクリーニングに対する政府資金の急増
    • 先天性疾患の負担増
    • 新生児疾患の有病率の増加
  • 主な市場抑制要因
    • 新生児スクリーニングの政策と実施における統一性の欠如
  • 主な市場機会
    • 新生児の遺伝子スクリーニング
  • 今後の動向
    • スクリーニングにおける機械学習と人工知能の統合
  • インパクト分析

第5章 新生児スクリーニング市場：アジア太平洋市場分析

  • アジア太平洋の新生児スクリーニング市場の売上高、2022年～2030年

第6章 アジア太平洋の新生児スクリーニング市場：収益と2030年までの予測：製品タイプ別

  • アジア太平洋の新生児スクリーニング市場：製品タイプ別売上高シェア（2022年～2030年）
  • 試薬およびアッセイキット
  • 検査機器

第7章 アジア太平洋の新生児スクリーニング市場：収益と2030年までの予測：技術別

  • アジア太平洋の新生児スクリーニング市場：2022年・2030年技術別売上高シェア（%）
  • タンデム質量分析（TMS）
  • 分子アッセイ
  • 免疫アッセイおよび酵素アッセイ
  • パルスオキシメトリー・スクリーニング技術
  • その他の技術

第8章 アジア太平洋の新生児スクリーニング市場：収益と2030年までの予測：検査タイプ別

  • アジア太平洋の新生児スクリーニング市場：2022年および2030年の検査タイプ別売上高シェア（%）
  • 乾燥血液スポット検査
  • 聴覚スクリーニング検査
  • 重症先天性心疾患（CCHD）検査
  • その他の検査タイプ

第9章 アジア太平洋の新生児スクリーニング市場：エンドユーザー別収益と2030年までの予測

  • アジア太平洋の新生児スクリーニング市場：2022年および2030年のエンドユーザー別売上高シェア（%）
  • 病院および診療所
  • 診断研究所

第10章 アジア太平洋の新生児スクリーニング市場：国別分析

  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他のアジア太平洋

第11章 アジア太平洋の新生児スクリーニング市場-業界情勢

  • 新生児スクリーニング市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • LifeCell International Pvt Ltd
  • Trivitron Healthcare Pvt Ltd
  • PerkinElmer Inc
  • Waters Corp
  • Bio-Rad Laboratories Inc
  • Masimo Corp
  • Natus Medical Inc.
  • Medtronic Plc

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Newborn Screening Market Segmentation
  • Table 2. Asia Pacific Newborn Screening Market, by Reagents and Assay Kits - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Asia Pacific Newborn Screening Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. China Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. China Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. China Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. China Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. China Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Japan Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Japan Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Japan Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Japan Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Japan Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Japan Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. India Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. India Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. India Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. India Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. India Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. India Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Australia Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Australia Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Australia Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Australia Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Australia Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Australia Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. South Korea Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. South Korea Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. South Korea Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 | (US$ Million)
  • Table 31. South Korea Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. South Korea Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. South Korea Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Rest of Asia Pacific Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Rest of Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Rest of Asia Pacific Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Rest of Asia Pacific Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Rest of Asia Pacific Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Rest of Asia Pacific Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Recent Organic Growth Strategies in Newborn Screening Market
  • Table 41. Recent Inorganic Growth Strategies in the Newborn Screening Market
  • Table 42. Glossary of Terms, Newborn Screening Market

List Of Figures

  • Figure 1. Asia Pacific Newborn Screening Market Segmentation, By Country
  • Figure 2. Newborn Screening Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Asia Pacific Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 6. Reagents and Assay Kits: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Instruments: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Asia Pacific Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 9. Tandem Mass Spectrometry (TMS): Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Molecular Assays: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Immunoassays and Enzymatic Assays: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Pulse Oximetry Screening Technology: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Other Technologies: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Asia Pacific Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 15. Dry Blood Spot Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hearing Screen Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Critical Congenital Heart Diseases (CCHD) Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Other Test Types: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Asia Pacific Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 20. Hospitals and Clinics: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diagnostic Laboratories: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Asia Pacific Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 23. Asia Pacific Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Growth Strategies in Newborn Screening Market
目次
Product Code: BMIRE00029605

The Asia Pacific newborn screening market was valued at US$ 270.13 million in 2022 and is expected to reach US$ 602.14 million by 2030; it is estimated to grow at a CAGR of 10.5% from 2022 to 2030.

Genetic Screening of Newborns Fuels the Asia Pacific Newborn Screening Market.

The demand for comprehensive genetic screening of newborns is rising with the deepening knowledge about the genetic causes of medical conditions and advancements in healthcare technologies. As a result, companies in the newborn screening market are developing innovative, cost-effective screening solutions. Yescarta and Zynteglo are two examples of authorized gene treatments for large B-cell lymphoma and beta-thalassemia. Further, the emergence of technologies conferring an ability to identify genetic predispositions to diseases at birth pave the way for personalized healthcare, aligning with the broader trend of precision medicine.

Screening for genetic diseases during pregnancy also focuses on the early detection of pregnancy-related problems. Next-generation sequencing aids in the prenatal screening of neonates with a sensitivity of above 95% for detecting aneuploidies (such as Down syndrome and Trisomy 21) or partial chromosomal abnormalities (duplications or deletions) in all chromosomes. Fluorescence in-situ hybridization (FISH) is employed to detect monogenic illnesses such as sickle cell anemia; it also aids in an effective preimplantation genetic diagnosis. Noninvasive procedures such as the cell-free fetal DNA approach using maternal plasma are the recent advancements in genetic tests. The embryonic DNA can be distinguished from maternal DNA pieces based on differences in their sizes. Real-time PCR with fluorescent probes, shotgun sequencing (Solexa or Illumina), or huge targeted parallel sequencing can be used to examine DNA associated with fetal medical conditions. This would allow doctors to provide early molecular interventions with certain pharmacological therapies (pharmacogenetics) and to transform cells, tissues, and organs physically and chemically if this type of genetic screening is further researched. Thus, advancements in methods for screening infants for genetic disorders hold immense potential for the overall newborn screening market.

Asia Pacific Newborn Screening Market Overview

The newborn screening market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The Asia -Pacific newborn screening market is segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia -Pacific. Asia -Pacific is expected to be the fastest-growing region in the global newborn screening market during 2022-2030. The projected growth of the market in this region can be associated with the high number of newborn births, the soaring prevalence of congenital diseases, rising awareness regarding early diagnosis of birth defects in newborns, and the presence of organizations working toward offering better solutions for newborn screening.

Screening of newborns in Asia -Pacific is gaining traction; government agencies in China, India, and other countries need to implement newborn screening programs owing to the high birth rate. According to the United Nations International Children's Emergency Fund (UNICEF), 67,385 babies are born in India each day, accounting for one-sixth of childbirths recorded globally in a day. In addition, India has become the most populated nation; as per Worldmapper, ~23 million babies were born in 2022, followed by China with the birth of 10 million babies. With the constantly soaring birth rate, the focus on infant care is increasing in India, as well as in other countries in Asia -Pacific.

Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Newborn Screening Market Segmentation

The Asia Pacific newborn screening market is segmented based on product type, technology, test type, end user, and country.

Based on product type, the Asia Pacific newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held a larger Asia Pacific newborn screening market share in 2022. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.

In terms of technology, the Asia Pacific newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held the largest Asia Pacific newborn screening market share in 2022.

Based on test type, the Asia Pacific newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held the largest Asia Pacific newborn screening market share in 2022.

By end user, the Asia Pacific newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held a larger Asia Pacific newborn screening market share in 2022.

Based on country, the Asia Pacific newborn screening market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific newborn screening market in 2022.

Bio-Rad Laboratories Inc, LifeCell International Pvt Ltd, Masimo Corp, Medtronic Plc, Natus Medical Inc, PerkinElmer Inc, Trivitron Healthcare Pvt Ltd, and Waters Corp are some of the leading companies operating in the Asia Pacific newborn screening market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Newborn Screening Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Surging Government Funding for Newborn Screening
    • 4.1.2 Rising Burden of Congenital Diseases
    • 4.1.3 Increasing Prevalence of Newborn Disorders
  • 4.2 Key Market Restraints
    • 4.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
  • 4.3 Key Market Opportunities
    • 4.3.1 Genetic Screening of Newborns
  • 4.4 Future Trends
    • 4.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
  • 4.5 Impact Analysis:

5. Newborn Screening Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 Asia Pacific Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 6.3 Reagents and Assay Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Assay Kits: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Asia Pacific Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
  • 6.4 Instruments
    • 6.4.1 Overview
    • 6.4.2 Instruments: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 Asia Pacific Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

7. Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 Asia Pacific Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Tandem Mass Spectrometry (TMS)
    • 7.3.1 Overview
    • 7.3.2 Tandem Mass Spectrometry (TMS): Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Molecular Assays
    • 7.4.1 Overview
    • 7.4.2 Molecular Assays: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunoassays and Enzymatic Assays
    • 7.5.1 Overview
    • 7.5.2 Immunoassays and Enzymatic Assays: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pulse Oximetry Screening Technology
    • 7.6.1 Overview
    • 7.6.2 Pulse Oximetry Screening Technology: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Technologies
    • 7.7.1 Overview
    • 7.7.2 Other Technologies: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

  • 8.1 Overview
  • 8.2 Asia Pacific Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 8.3 Dry Blood Spot Test
    • 8.3.1 Overview
    • 8.3.2 Dry Blood Spot Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Hearing Screen Test
    • 8.4.1 Overview
    • 8.4.2 Hearing Screen Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Critical Congenital Heart Diseases (CCHD) Test
    • 8.5.1 Overview
    • 8.5.2 Critical Congenital Heart Diseases (CCHD) Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Test Types
    • 8.6.1 Overview
    • 8.6.2 Other Test Types: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Newborn Screening Market - Country Analysis

  • 10.1 Asia Pacific Newborn Screening Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific Newborn Screening Market, by Country
      • 10.1.2.1 China
        • 10.1.2.1.1 China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.2 China: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.1.2.1 China: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.1.2.2 China: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.1.3 China: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.1.4 China: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.1.5 China: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.2 Japan
        • 10.1.2.2.1 Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.2 Japan: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.2.2.1 Japan: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.2.2.2 Japan: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.2.3 Japan: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.2.4 Japan: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.2.5 Japan: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.3 India
        • 10.1.2.3.1 India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.2 India: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.3.2.1 India: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.3.2.2 India: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.3.3 India: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.3.4 India: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.3.5 India: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.4 Australia
        • 10.1.2.4.1 Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.2 Australia: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.4.2.1 Australia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.4.2.2 Australia: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.4.3 Australia: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.4.4 Australia: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.4.5 Australia: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.5 South Korea
        • 10.1.2.5.1 South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.2 South Korea: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.5.2.1 South Korea: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.5.2.2 South Korea: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.5.3 South Korea: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.5.4 South Korea: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.5.5 South Korea: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.6 Rest of Asia Pacific
        • 10.1.2.6.1 Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.2 Rest of Asia Pacific: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.6.2.1 Rest of Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.6.2.2 Rest of Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.6.3 Rest of Asia Pacific: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.6.4 Rest of Asia Pacific: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.6.5 Rest of Asia Pacific: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

11. Asia Pacific Newborn Screening Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Newborn Screening Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 LifeCell International Pvt Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Trivitron Healthcare Pvt Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 PerkinElmer Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Waters Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Bio-Rad Laboratories Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Masimo Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Natus Medical Inc.
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medtronic Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms